Research Article
[Retracted] Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer
Figure 5
Virtual docking of baicalin (a), ignavine (b), lactiflorin (c), neokadsuranic acid B (d), and deoxyaconitine (e) with CDK2.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |